Join Us at the 30th Annual
Interdisciplinary
Breast Center Conference




We are showcasing MammaPrint® and BluePrint® genomic tests for comprehensive profiling of early-stage breast cancer.

If you missed us at the NCBC meeting, here’s a recording of the virtual symposium


Attend our virtual presentation titled:

Genomic Profiling in Early Stage Breast Cancer

Saturday, April 17 12:10 PM PST

William Audeh, MD, MS

Dr. William Audeh is a medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia as Chief Medical Officer, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.

FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Our Tests

At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor.

Genomic Testing Cell Photo

Landmark Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

Two women reading about genomic breast cancer results

Latest News

The most recent data and news from Agendia to keep you up-to-date on how our tests can support you and your patients.